Equillium Inc (NASDAQ:EQ) CEO Bruce Steel sat down with Proactive’s Christine Corrado at BIO CEO in New York. The San Diego-based biotechnology company is developing products for autoimmune and inflammatory disorders.
Equillium 'excited' about data from three different Phase IB clinical studies in second half of 2020
Quick facts: Equillium
Price: 2.62 USD
Market Cap: $45.53 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE